Sun Pharma bullish on specialty biz, looks to expand the segment to new geographies
Posted by
www.biotecnika.org
Sharing information with shareholders, Sun Pharmaceutical Industries
Managing Director Dilip Shanghvi said the company's strategy of
developing the specialty business as an additional growth engine has
started delivering results, with a gradual ramp up in specialty
revenues.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-pharma-bullish-on-specialty-biz-looks-to-expand-the-segment-to-new-geographies/articleshow/78344062.cms
Subscribe to:
Post Comments (Atom)
Post a Comment